One-third of the global population, mostly in sub-Saharan Africa, lacks consistent access to essential medicines. This descriptive study assessed the level of stock-outs and whether distance to district pharmacy, supervision visits or delays in drug delivery from district pharmacy to health centers were associated with stock-outs in 15 rural health centers in northern Rwanda. We extracted data from stock cards, dispensing records and health center registers. One tracer drug, mebendazole, had no stock-outs. Quinine had the most stock-outs, an average of 10.5 months of stock-outs in 10 health centers. No association was found between drug stock-out and distance, supervision visits or delays in drug delivery. We hypothesize that observed stock-outs could be attributed to availability of other dosages of the same medicine, special orders during campaigns, staff turn-over and logistical issues beyond health centers' capacity such as delays in importation. These should be explored more in future studies.
Introduction
Majority of the developing countries, mostly in subSaharan Africa, lack consistent availability and access to essential health products (Wagenaar et al, 2014; Line & Cammack, 2013) . Availability, access and affordability of safe drug products must be addressed to facilitate high quality healthcare (Elamin et al, 2010) . This is challenging in resource-poor settings (Häfele-Abah & Neuhann, 2010) . Despite increased affordability of drugs, most countries in sub-Saharan Africa struggle with pharmacy supply chain management (Sekabembe, 2009) . Specific challenges include high and increasing outpatient attendance, geographical distance from central stores to local pharmacies, and challenges in importing drugs from outside countries (Edmund & Reuben, 2013; Hayford, 2011) .
In Rwanda, the majority of health care delivery happens at the health center level, with more complicated cases referred to district hospitals. Each health center has a pharmacy to support healthcare delivery. Stock-outs at these pharmacies could limit the effectiveness of care offered. Few studies have assessed essential medicine stock-outs in rural pharmacies in sub-Saharan Africa (Wagenaar et al, 2014; Wild & Cammack, 2013) and to our knowledge, none has been conducted in Rwanda.
To understand the level of stock-outs of essential medicines in rural health facilities in Rwanda, this study examined the proportion of drug stock-out and factors related to stock-out for ten tracer drugs in 15 health centers in rural Rwanda. Our study received technical review from Partners In Health (PIH) Research Committee and the Rwanda National Health Research Committee. Because we used routinely collected program data, we received an ethical review exemption from the Rwanda National Ethics Committee.
Methods
This descriptive study was conducted in 15 health centers in Burera District, a rural district in northern Rwanda, between January 1 and December 31, 2013. The health services in Burera District are led by the Ministry of Health and supported by PIH, a non-governmental organization. The Rwanda Biomedical Center (RBC) and BUFMAR (a faith-based organization) purchase and distribute medicines to district pharmacies. In case *Corresponding author: ndilouis@gmail.com of lack of pharmaceutical products in the public sector, with the authorization of the Minister of Health, district pharmacies can purchase medicines from private medical stores or receive donations from non-governmental organizations.
Health center pharmacies are supplied by the district pharmacy. A nurse assigned to the health center pharmacy records stock transactions, monitors the stock levels and uses recent consumption data to place the monthly order to the district pharmacy through paperbased stock management cards. If stock levels drop below predetermined buffer levels, the nurse may place an emergency order to the district pharmacy. Monthly reports on stock level are sent to the district pharmacy which are then aggregated and sent to the central level.
A quick survey of stock records at Burera District Hospital was conducted to determine the ten commonly used medicines that were also in the essential list of medicine. Data was collected on the ten tracer drugs selected by the study investigators based on the consumption patterns. These drugs represent a cross section of drug types that are used for common illnesses in Burera District: Amoxicillin 250mg capsule, Penicillin V 250mg tablet, Paracetamol 500mg tablet, Quinine 300mg tablet, Ibuprofen 200mg tablet, Cotrimoxazole 480mg tablet, Mebendazole 500mg tablet, Chlorpheniramine 4mg tablet, Promethazine 250mg tablet and Oral Rehydration Salt sachets. For each drug, the number of days of stock-out was collected for each month. We assessed health facilities with any stockout, the average number of months with any stock-out and the average number of days of stock-out per month.
For each health center, the average monthly proportion of drugs with any stock-out, distance from health center to the district pharmacy, number of months with any supervision visits (from health center register), average number of days between order to delivery (from purchase orders and delivery notes) and availability of motorcycle or vehicle for transportation (as reported by health center leaders) were recorded. The health centers were further classified as low level stock-outs (0-5% of drugs stocked out per month), medium level stock-outs (>5-10% of drugs stocked out per month) and high level stockouts (>10% of drugs stocked out per month) based on observed stock-outs and compared with potential factors related to stock-outs. We performed univariate analysis, reporting means and proportions and also used a graphical bivariate analysis assessing the relationship between stock-outs level and the factors hypothesized.
Results
For the ten tracer drugs assessed, only one tracer drug, mebendazole, had no recorded stock-outs in any health center in 2013 (Table 1) . Quinine had the most stock-outs, with 10 health centers (66.6%) experiencing an average of 10.5 months of stock-outs, often lasting for the entire month. For each of the remaining eight drugs, at least one and as many as six health facilities experienced stockouts, and the number of months with stock-out for each drug ranged from 1.0-3.5 months. The classification of stock-out levels was based on the range of stock-out levels seen that was between 0.0-24.2%. Six health centers (40%) were classified as having high levels of drug stock-out, five health centers (33.3%) as medium levels and four health centers (26.7%) as low levels or no stock-outs (Figure 1 ).
Figure 1. Comparing factors related to stock-outs in health centers with low, middle and high levels of drug stock-outs
The distance between health centers and district pharmacy ranged from 1-82 km. The number of supervision visits per facility ranged from 0-7 during the year, with two health centers (13.3%) not receiving any supervisory visits. The average days between order and delivery ranged from 12-38 days. All health centers had access to a motorcycle or vehicle for transportation. Upon further analysis, there was no relationship between level of stockout and distance from health center to district pharmacy, supervision visits and days between order and delivery.
Discussion
The present study found out that there was a variation in the presence and level of stock-outs of the different drugs. Mebendazole was the only drug without any documented stock-outs while quinine had high levels of stock-outs with 66% of the facilities experiencing at least one stock-out over the study period. Reasons for these extremes should be studied to improve supply chain management for health center pharmacies in the future. For amoxicillin, ibuprofen and cotrimoxazole, our study included the lower dosage medicines that are commonly prescribed to children. In some cases, higher dosages were available during stock-outs of the lower dosages but would require that tablets be broken to achieve appropriate dosing for children. For drugs such as promethazine and chlorpheniramine, stock outs could be due to low or irregular consumption, as observed in other studies (Robertson, 2009 ).
The study results showed no trend between drug stockout and the factors we originally hypothesized. In Rwanda, health center pharmacies are managed by staff with limited pharmaceutical technical and supply chain management capacity (Ministry of Health, 2012) . This situation has been associated with inability to quantify medical supplies appropriately and in timely fashion at health facility level resulting in imprecise forecasting of pharmaceutical requirements by the Medical Procurement and Distribution Department (MPDD) (Ministry of Health, 2012) . In response to that, however, the Rwandan government in its third Health Sector Strategic Plan for 2012-2018 (HSSP-III) set a target of raising the level of health facility staff skills in pharmaceutical supply management (Ministry of Health, 2012) .
In Rwanda, the Logistic Management Information System (LMIS) has been paper-based, although the rolling out of electronic LMIS is in progress (Ministry of Health, 2012) . The use of paper-based LMIS at the time of the present study may have contributed to some observed stockouts, as reported elsewhere (Desale, Taye, Belay, & Nigatu, 2013; USAID | DELIVER PROJECT, 2012) . Further, the ongoing deployment of electronic LMIS to replace one which is paper-based will require harmonization of tools used by all partners engaged in the procurement and supply chain management (Ministry of Health, 2012) , and the impact of this harmonization on drug stock-outs should be studied. Finally, other studies on drug stock-outs in health centers have identified a weak supply chain management system, staff motivation, poor stock records and budget allocation as contributing factors (Wagenaar et al, 2014; Penfold et al, 2013) . Future studies should assess these factors' contributions to drug stock-outs in Rwanda.
Study limitations
There are a few limitations to our study. We only assessed one rural district, Burera. However, since most district in rural areas tend to experience almost similar challenges, the results of this study might serve as a useful resource to other health managers. Likewise, the use of secondary data gathered in routine execution of logistic activities left many questions unanswered, and will in future require specially designed questionnaire to seek for the answers.
Conclusion
Up to 73% of health facilities faced a challenge of medium to high levels of stock outs. Limited capacity of staff managing logistics and supplies at health facilities could be contributing to the observed stockouts, a situation also identified by government of Rwanda and plans for capacity building are underway. Future research to assess the role of electronic Logistic Management Information System in the availability of drugs at health facilities as well as research on the effect of pharmacy staff qualifications and turn-over on stock-outs will go a long way to identifying other factors that might contribute drug stock-outs.
